Usona in the News
Wisconsin scientists are leaders in testing psychedelic treatments for mental health
Wisconsin institute makes psilocybin used in national research.
September 4, 2025 | Wisconsin Public Radio
These Toads Have Psychedelic Powers, but They’d Prefer to Keep It Quiet
Dr. Anny Ortiz is collaborating on conservation efforts to protect the Sonoran Desert toad.
July 10, 2025 | New York Times
Usona Hosts Inaugural U-PEP Faculty Fellows Program
Usona Institute recently welcomed the first cohort of Faculty Fellows from the University Psychedelic Education Program (U-PEP) to its campus.
June 24, 2025 | Read More
UW-Madison center sees promise in using psychedelics for addiction, PTSD, depression
Usona, a not-for-profit medical research organization, is one of the largest facilities in the country developing psilocybin...
May 29, 2025 | Milwaukee Journal Sentinel
Wisconsin is on the front lines of psychedelic research that could reach millions
Researchers say a drug found in magic mushrooms shows promise for helping treat depression...
October 14, 2024 | Wisconsin Public Radio
Pioneering psychiatrist Dr. Charles L. Raison explores consciousness and psychedelics in mental health research
Dr. Charles L. Raison discusses his research on psychedelics and mental health, exploring how conscious experience impacts healing.
September 6, 2024 | Genomic Press
Psilocybin for Depression: An Interview with Dr. Charles Raison
Dr. Charles Raison discusses psilocybin's potential in treating depression on the MPR Weekly Dose Podcast.
May 7, 2024 | MPR Weekly Dose Podcast
Charles L. Raison: Elucidating the role of conscious experience in the therapeutic effects of psychedelics as a means to optimize clinical outcomes
Dr. Charles Raison talks with Genomic Press about his path from science enthusiast to leading psychedelic therapy researcher and its impacts.
March 14, 2024 | Genomic PressUpdates
Usona Statement on Phase 3 Study of Psilocybin for Major Depressive Disorder (MDD) (uAspire)
March 20, 2024
Usona Institute Research Unveils New Compounds with Observed Psychedelic-like Activity
January 10, 2024
Usona statement on JAMA publication of PSIL201 data
August 31, 2023
Media Inquiries
MEDIA REQUESTMedia Inquiries
Please contact mediarequests@usonainstitute.org with the following information:
- Name and organization
- Description of what you would like to cover
- Deadline